...
Dataset wrap |
---|
|
Rowcaps |
---|
Rows 1-3: | Show the target response (RSTESTCD = "TRGRESP") and non-target response (RSTESTCD = "NTRGRESP") tests and corresponding overall response (RSTESTCD = "OVRLRESP") at the week 6 assessment. RSLNKGRP is populated on the Overall Response record only and used to associate the overall response to underlying data in other domains (e.g., TR). Note that "NE" (Not evaluable) is a valid Overall Response value per the RECIST 1.1 criteria which means that RSORRES is "NE" rather than represented in RSSTAT. | Rows 4-12: | Show the week 12, week 20, and week 28 responses. | Rows 13-20: | At week 36, the new lesion progression test is used to represent an equivocal new lesion (RSTESTCD = "NEWLPROG" and RSORRES = "EQUIVOCAL") and to represent at week 44 that there are unequivocal new lesions (RSTESTCD = "NEWLPROG" and RSORRES = "UNEQUIVOCAL"). There are different methods of collecting data when there is an equivocal new lesion. Some sponsors update the overall response when equivocal evidence of a new lesion has been confirmed at a later assessment (i.e., documented as unequivocal). Other sponsors derive (in ADaM) the new progression date as the date when the new lesion was first identified. |
|
Dataset2 |
---|
Row | STUDYID | DOMAIN | USUBJID | RSSEQ | RSLNKGRP | RSTESTCD | RSTEST | RSCAT | RSORRES | RSSTRESC | RSEVAL | EPOCH | VISITNUM | VISIT | RSDTC | RSDY |
---|
1 | EX11111 | RS | 90001 | 1 |
| TRGRESP | Target Response | RECIST 1.1 | NE | NE | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-15 | 46 | 2 | EX11111 | RS | 90001 | 2 |
| NTRGRESP | Non-Target Response | RECIST 1.1 | NE | NE | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-15 | 46 | 3 | EX11111 | RS | 90001 | 3 | A2 | OVRLRESP | Overall Response | RECIST 1.1 | NE | NE | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-15 | 46 | 4 | EX11111 | RS | 90001 | 4 |
| TRGRESP | Target Response | RECIST 1.1 | SD | SD | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-39 | 88 | 5 | EX11111 | RS | 90001 | 5 |
| NTRGRESP | Non-Target Response | RECIST 1.1 | NON-CR/NON-PD | NON-CR/NON-PD | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-29 | 88 | 6 | EX11111 | RS | 90001 | 6 | A3 | OVRLRESP | Overall Response | RECIST 1.1 | SD | SD | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-29 | 88 | 7 | EX11111 | RS | 90001 | 7 |
| TRGRESP | Target Response | RECIST 1.1 | PR | PR | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-30 | 147 | 8 | EX11111 | RS | 90001 | 8 |
| NTRGRESP | Non-Target Response | RECIST 1.1 | NON-CR/NON-PD | NON-CR/NON-PD | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-30 | 147 | 9 | EX11111 | RS | 90001 | 9 | A4 | OVRLRESP | Overall Response | RECIST 1.1 | PR | PR | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-30 | 147 | 10 | EX11111 | RS | 90001 | 10 |
| TRGRESP | Target Response | RECIST 1.1 | PR | PR | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-25 | 204 | 11 | EX11111 | RS | 90001 | 11 |
| NTRGRESP | Non-Target Response | RECIST 1.1 | NON-CR/NON-PD | NON-CR/NON-PD | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-25 | 204 | 12 | EX11111 | RS | 90001 | 12 | A5 | OVRLRESP | Overall Response | RECIST 1.1 | PR | PR | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-25 | 204 | 13 | EX11111 | RS | 90001 | 13 |
| TRGRESP | Target Response | RECIST 1.1 | CR | CR | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 14 | EX11111 | RS | 90001 | 14 |
| NTRGRESP | Non-Target Response | RECIST 1.1 | CR | CR | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 15 | EX11111 | RS | 90001 | 15 |
| NEWLPROG | New Lesion Progression | RECIST 1.1 | EQUIVOCAL | EQUIVOCAL | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 16 | EX11111 | RS | 90001 | 16 | A6 | OVRLRESP | Overall Response | RECIST 1.1 | CR | CR | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 17 | EX11111 | RS | 90001 | 17 |
| TRGRESP | Target Response | RECIST 1.1 | PD | PD | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-14 | 313 | 18 | EX11111 | RS | 90001 | 18 |
| NTRGRESP | Non-Target Response | RECIST 1.1 | CR | CR | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-14 | 313 | 19 | EX11111 | RS | 90001 | 19 |
| NEWLPROG | New Lesion Progression | RECIST 1.1 | UNEQUIVOCAL | UNEQUIVOCAL | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-14 | 313 | 20 | EX11111 | RS | 90001 | 20 | A7 | OVRLRESP | Overall Response | RECIST 1.1 | PD | PD | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-14 | 313 |
|
|
The following supprs.xpt table shows the data on the reason that the response was not evaluable (QNAM = "RSREASNE") in the case where the reason is collected.
...